Medical Journals

Transcriptional Co-activator P75 Binds and Tethers the Myc-interacting Protein Jpo2 to Chromatin.

Authors:
  • Maertens Goedele N
  • Cherepanov Peter
  • Engelman Alan

From: Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

Journal of cell science

  • Publish Date: Jun 2006
  • ISSN: 0021-9533
  • Volume: 119
  • Issue: Pt 12
  • Pages: 2563-71
  • Medium: Print
  • Language: English
  • Citation (JAMA): Maertens Goedele N, Cherepanov Peter, Engelman Alan, et al. Transcriptional Co-activator P75 Binds and Tethers the Myc-interacting Protein Jpo2 to Chromatin.. J. Cell. Sci. Jun 2006;119:2563-71

Abstract

Transcriptional co-activator p75 is implicated in human cancer, autoimmunity and replication of human immunodeficiency virus type 1 (HIV-1) as a dominant integrase-interacting protein. Although characterized as chromatin associated, the normal biological role(s) of p75 remains fairly unclear. To gain insight into p75 function, we have characterized its cellular binding partners and report that JPO2, a recently identified Myc-binding protein, associates with p75 in vitro and in vivo. The pseudo HEAT repeat analogous topology (PHAT) domain of p75, which mediates its interaction with integrase, also mediates the interaction with JPO2, and recombinant integrase protein competes with JPO2 protein for binding to p75 in vitro. JPO2 binds p75 through a 61-residue (amino acids 58-119) region that is distinct from its Myc-interacting domain. In cells, JPO2 and p75 co-localize throughout the cell cycle, and both proteins concentrate on condensed chromosomes during mitosis. Strikingly, the association of JPO2 with chromatin strictly depends upon p75, similar to that of ectopically expressed integrase. Also similar to its effect on integrase, p75 stabilizes intracellular steady-state levels of JPO2 protein. Our results suggest a role for p75 in the Myc regulatory network, and indicate that p75 is a general adaptor protein tethering divergent factors to chromatin through its versatile integrase-binding domain.

Mesh Headings (Keywords): Binding Sites, Cell Line, Cells, Cultured, Chromatin, Hela Cells, Humans, Intercellular Signaling Peptides and Proteins, Nuclear Proteins, Protein Binding, Repressor Proteins, Transcription, Genetic


Check for Full Text / PubMed Unique Identifier (PMID): 16735438


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.